Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (151-160 of 284) with videos related to

Pageof 29
Sort By:
Bone Marrow Transplantation|June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Leukemia & Lymphoma|March 1, 1996
A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomasN Vey, D Blaise, P Tiberghien, et al.
Bone Marrow Transplantation|August 26, 1998
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantationC Faucher, C Fortanier, P Viens, et al.
Bone Marrow Transplantation|February 14, 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remissionH de Lavallade, C Faucher, S Fürst, et al.
European Cytokine Network|February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantationN Vey, P Viens, C Fossat, et al.
Bone Marrow Transplantation|January 23, 2002
Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case reportM Mohty, C Faucher, B Gaugler, et al.
Cytotherapy|June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMTM Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation|February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaH de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation|November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicityS Garciaz, D Coso, J-M Schiano de Collela, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1992
Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancerM S Negrier, C N Pourreau, P A Palmer, et al.
Pageof 29

Showing results (151-160 of 284) with videos related to

Sort By:
Pageof 29
Bone Marrow Transplantation|June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Leukemia & Lymphoma|March 1, 1996
A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomasN Vey, D Blaise, P Tiberghien, et al.
Bone Marrow Transplantation|August 26, 1998
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantationC Faucher, C Fortanier, P Viens, et al.
Bone Marrow Transplantation|February 14, 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remissionH de Lavallade, C Faucher, S Fürst, et al.
European Cytokine Network|February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantationN Vey, P Viens, C Fossat, et al.
Bone Marrow Transplantation|January 23, 2002
Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case reportM Mohty, C Faucher, B Gaugler, et al.
Cytotherapy|June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMTM Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation|February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaH de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation|November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicityS Garciaz, D Coso, J-M Schiano de Collela, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1992
Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancerM S Negrier, C N Pourreau, P A Palmer, et al.
Pageof 29